Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008427
Filing Date
2017-11-08
Accepted
2017-11-07 17:32:42
Documents
50
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20170930x10q.htm 10-Q 1710778
2 EX-31.1 xncr-20170930ex3117a4aec.htm EX-31.1 19328
3 EX-31.2 xncr-20170930ex312192a87.htm EX-31.2 19348
4 EX-32.1 xncr-20170930ex321805556.htm EX-32.1 10461
  Complete submission text file 0001558370-17-008427.txt   6293697

Data Files

Seq Description Document Type Size
5 EX-101.INS xncr-20170930.xml EX-101.INS 1448903
6 EX-101.SCH xncr-20170930.xsd EX-101.SCH 34000
7 EX-101.CAL xncr-20170930_cal.xml EX-101.CAL 42932
8 EX-101.DEF xncr-20170930_def.xml EX-101.DEF 130322
9 EX-101.LAB xncr-20170930_lab.xml EX-101.LAB 381363
10 EX-101.PRE xncr-20170930_pre.xml EX-101.PRE 257515
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 171184525
SIC: 2834 Pharmaceutical Preparations